+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
GMP-grade Protein Production Services Market - Global Forecast 2026-2032- Product Image
GMP-grade Protein Production Services Market - Global Forecast 2026-2032- Product Image
Sale

GMP-grade Protein Production Services Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125107
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The GMP-grade Protein Production Services Market is projected to reach USD 769.83 Million in 2026. It is expected to continue growing at a CAGR of 7.68%, reaching USD 1.20 Billion by 2032.

GMP-Grade Protein Production Services: Executive Overview

GMP-grade protein production services support the development and manufacture of proteins used in regulated medicines, vaccines, diagnostics, and advanced therapies. The field spans process development, cell-line and strain engineering, upstream and downstream processing, analytical characterization, formulation, fill-finish, quality control, and regulatory documentation. Demand is shaped by the need for reproducible supply, validated processes, stringent contamination control, and reliable technology transfer across development and commercial stages.

How Regulation, Complexity, and Outsourcing Are Reshaping Protein Manufacturing

The landscape is shifting toward integrated, flexible manufacturing models that can accommodate recombinant proteins, antibodies, enzymes, peptides, and other biologics. Sponsors increasingly evaluate providers on quality-system maturity, process comparability, single-use capability, cold-chain execution, and the ability to move efficiently from laboratory development to clinical and commercial production. Regulatory expectations for data integrity, traceability, viral safety, impurity control, and lifecycle management are also encouraging deeper standardization and earlier quality-by-design work.

Artificial Intelligence Improves Development, Quality, and Operational Decision-Making

Artificial intelligence is being applied to protein sequence design, expression-system selection, process-parameter optimization, formulation screening, deviation investigation, and predictive maintenance. Its practical value depends on well-curated experimental data, validated analytical methods, controlled model changes, and clear human oversight. In regulated settings, AI-generated recommendations must remain explainable, reproducible, secure, and supported by documented validation before they influence batch release, process control, or regulatory submissions.

Regional Insights: Capacity, Regulation, and Supply-Chain Priorities Differ

North America combines deep biopharmaceutical development activity with mature regulatory and quality infrastructure, while Europe emphasizes harmonized compliance, sustainability, and cross-border manufacturing coordination. Asia-Pacific is strengthening domestic biologics capabilities and expanding development and manufacturing capacity, with established expertise in Japan and South Korea and rapidly advancing ecosystems elsewhere. The Middle East is investing in healthcare localization and technology transfer; Africa is focused on strengthening biomanufacturing foundations and access; and Latin America is developing regional production, quality, and cold-chain capabilities while managing dependence on imported inputs and specialized equipment.

Group Insights: Alliances Shape Standards, Access, and Manufacturing Resilience

ASEAN economies are pursuing greater regional pharmaceutical integration, making interoperable quality systems and cross-border logistics increasingly important. BRICS members reflect varied manufacturing maturity but share interests in domestic capability, technology access, and supply-chain resilience. The European Union benefits from regulatory alignment and coordinated industrial policy, while the G7 emphasizes advanced research, high-quality manufacturing, and secure supply networks. GCC states are prioritizing healthcare localization and investment, and NATO members are increasingly attentive to continuity of critical medical supply and trusted manufacturing infrastructure.

Country Insights: Distinct Capabilities and Policy Contexts Guide Adoption

Australia supports biologics research and specialized manufacturing within a geographically dispersed supply environment. Brazil and Mexico are expanding local pharmaceutical and biotechnology capabilities, with regulatory coordination and technology transfer remaining important. Canada and the United States offer extensive research, clinical, and manufacturing ecosystems. China and India continue to strengthen domestic biologics production, process expertise, and supply-chain depth. Japan and South Korea combine advanced quality systems with strong scientific and industrial bases. France, Germany, Italy, Spain, and the United Kingdom contribute established research, regulatory, and manufacturing capabilities, while Russia’s operating environment is shaped by localization priorities, sanctions exposure, and access to specialized technologies.

Recommendations for Leaders: Build Quality, Flexibility, and Digital Readiness

Industry leaders should select service partners through a risk-based assessment covering regulatory history, technical transfer performance, analytical depth, contamination controls, capacity flexibility, data integrity, and supply continuity. They should define critical quality attributes and process controls early, preserve comparability evidence across scale changes, and maintain qualified alternatives for essential raw materials and production steps. Investment in standardized data architectures and carefully governed AI tools can improve development speed and investigation quality, but implementation should be phased through validated use cases, cybersecurity controls, training, and documented accountability.

Research Methodology: Evidence-Led Assessment of the Service Landscape

This executive summary uses a structured qualitative review of the GMP-grade protein production services landscape. The assessment considers service scope, regulatory expectations, manufacturing technologies, quality requirements, outsourcing drivers, regional infrastructure, group-level policy environments, and country-specific capabilities. Insights are synthesized from publicly available regulatory frameworks, scientific and technical literature, industry operating practices, and documented biomanufacturing developments. Claims are framed at the strategic level and avoid unsupported numerical estimates, market sizing, market shares, forecasts, and company-specific comparisons.

Conclusion: Reliable Execution Is the Core Competitive Differentiator

GMP-grade protein production services are becoming more integrated, data-driven, and quality-centered as biologic modalities grow more complex and sponsors seek dependable development-to-manufacturing pathways. Regional capabilities remain uneven, but investment in validated processes, skilled personnel, resilient supply chains, and interoperable regulatory practices is broadening the global base. Leaders that combine technical flexibility with rigorous quality governance, transparent data practices, and responsible AI adoption will be best positioned to support compliant and reliable protein supply.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. GMP-grade Protein Production Services Market, by Protein Type
7.1. Introduction
7.2. Enzymes
7.2.1. Lipases
7.2.2. Nucleases
7.2.3. Polymerases
7.2.4. Proteases
7.3. Growth Factors
7.3.1. EGF
7.3.2. FGF
7.3.3. PDGF
7.3.4. VEGF
7.4. Monoclonal Antibodies
7.4.1. Bispecific Antibodies
7.4.2. IgA
7.4.3. IgE
7.4.4. IgG
7.4.5. IgM
7.5. Recombinant Proteins
7.5.1. Cytokines
7.5.2. Insulin
7.5.3. Interferons
7.6. Vaccines
7.6.1. Bacterial Vaccines
7.6.2. Conjugate Vaccines
7.6.3. Subunit Vaccines
7.6.4. Viral Vaccines
8. GMP-grade Protein Production Services Market, by Expression System
8.1. Introduction
8.2. Bacterial
8.2.1. Bacillus
8.2.2. E Coli
8.3. Insect
8.3.1. High Five Cells
8.3.2. Sf9 Cells
8.4. Mammalian
8.4.1. CHO Cells
8.4.2. HEK Cells
8.4.3. SP2/0 Cells
8.5. Plant
8.5.1. Rice
8.5.2. Tobacco
8.6. Yeast
8.6.1. Pichia Pastoris
8.6.2. Saccharomyces Cerevisiae
9. GMP-grade Protein Production Services Market, by Purity Grade
9.1. Introduction
9.2. High Purity
9.3. Standard
9.4. Ultra High Purity
10. GMP-grade Protein Production Services Market, by Scale
10.1. Introduction
10.2. Commercial Scale
10.3. Lab Scale
10.4. Pilot Scale
11. GMP-grade Protein Production Services Market, by Application
11.1. Introduction
11.2. Diagnostics
11.2.1. Immunoassays
11.2.2. Molecular Diagnostics
11.3. Industrial Enzymes
11.3.1. Detergent Enzymes
11.3.2. Food Enzymes
11.3.3. Pharmaceutical Enzymes
11.4. Research Reagents
11.4.1. Academic Research
11.4.2. Industrial Research
11.5. Therapeutics
11.5.1. Autoimmune Disorders
11.5.2. Infectious Diseases
11.5.3. Oncology
12. GMP-grade Protein Production Services Market, by End User
12.1. Introduction
12.2. Academic Institutes
12.3. Biotechnology Companies
12.4. Contract Research Organizations
12.5. Pharmaceutical Companies
12.6. Research Institutes
13. GMP-grade Protein Production Services Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. GMP-grade Protein Production Services Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. GMP-grade Protein Production Services Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. AGC Biologics ApS
17.2. Boehringer Ingelheim International GmbH
17.3. Catalent, Inc.
17.4. Fujifilm Diosynth Biotechnologies, LLC
17.5. Lonza Group AG
17.6. Merck KGaA
17.7. Novasep SA
17.8. Novozymes
17.9. Samsung Biologics Co., Ltd.
17.10. Thermo Fisher Scientific Inc.
17.11. WuXi Biologics (Cayman) Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global GMP-grade Protein Production Services Market, Years Considered for the Study
FIGURE 2. Global GMP-grade Protein Production Services Market, Research Design
FIGURE 3. Global GMP-grade Protein Production Services Market, Research Framework
FIGURE 4. Global GMP-grade Protein Production Services Market, Data Triangulation
FIGURE 5. Global GMP-grade Protein Production Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global GMP-grade Protein Production Services Market Size, by Protein Type, 2025 vs 2032 (%)
FIGURE 7. Global GMP-grade Protein Production Services Market Size, by Protein Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global GMP-grade Protein Production Services Market Size, by Expression System, 2025 vs 2032 (%)
FIGURE 9. Global GMP-grade Protein Production Services Market Size, by Expression System, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global GMP-grade Protein Production Services Market Size, by Purity Grade, 2025 vs 2032 (%)
FIGURE 11. Global GMP-grade Protein Production Services Market Size, by Purity Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global GMP-grade Protein Production Services Market Size, by Scale, 2025 vs 2032 (%)
FIGURE 13. Global GMP-grade Protein Production Services Market Size, by Scale, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global GMP-grade Protein Production Services Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global GMP-grade Protein Production Services Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global GMP-grade Protein Production Services Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global GMP-grade Protein Production Services Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global GMP-grade Protein Production Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global GMP-grade Protein Production Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global GMP-grade Protein Production Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global GMP-grade Protein Production Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global GMP-grade Protein Production Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global GMP-grade Protein Production Services Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global GMP-grade Protein Production Services Market Segmentation & Coverage
TABLE 2. Global GMP-grade Protein Production Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global GMP-grade Protein Production Services Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 4. Global Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Lipases Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Lipases Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Lipases Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Nucleases Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Nucleases Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Nucleases Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Polymerases Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Polymerases Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Polymerases Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Proteases Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Proteases Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Proteases Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Growth Factors Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Growth Factors Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Growth Factors Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global EGF Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global EGF Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global EGF Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global FGF Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global FGF Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global FGF Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global PDGF Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global PDGF Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global PDGF Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global VEGF Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global VEGF Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global VEGF Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Bispecific Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Bispecific Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Bispecific Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global IgA Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global IgA Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global IgA Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global IgE Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global IgE Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global IgE Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global IgG Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global IgG Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global IgG Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global IgM Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global IgM Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global IgM Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Recombinant Proteins Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Recombinant Proteins Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Recombinant Proteins Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Cytokines Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Cytokines Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Cytokines Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Insulin Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Insulin Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Insulin Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Interferons Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Interferons Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Interferons Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Bacterial Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Bacterial Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Bacterial Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Conjugate Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Conjugate Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Conjugate Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Subunit Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Subunit Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Subunit Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Viral Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Viral Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Viral Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global GMP-grade Protein Production Services Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 80. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Bacillus Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Bacillus Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Bacillus Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global E Coli Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global E Coli Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global E Coli Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Insect Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Insect Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Insect Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global High Five Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global High Five Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global High Five Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Sf9 Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Sf9 Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Sf9 Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Mammalian Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Mammalian Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Mammalian Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global CHO Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global CHO Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global CHO Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global HEK Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global HEK Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global HEK Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global SP2/0 Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global SP2/0 Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global SP2/0 Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Plant Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Plant Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Plant Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Rice Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Rice Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Rice Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Tobacco Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Tobacco Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Tobacco Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Yeast Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Yeast Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Yeast Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Pichia Pastoris Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Pichia Pastoris Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Pichia Pastoris Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Saccharomyces Cerevisiae Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Saccharomyces Cerevisiae Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Saccharomyces Cerevisiae Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global GMP-grade Protein Production Services Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 129. Global High Purity Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global High Purity Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global High Purity Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Standard Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Standard Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Standard Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Ultra High Purity Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Ultra High Purity Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Ultra High Purity Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global GMP-grade Protein Production Services Market Size, by Scale, 2017-2032 (USD Million)
TABLE 139. Global Commercial Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Commercial Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Commercial Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Lab Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Lab Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Lab Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Pilot Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Pilot Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Pilot Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global GMP-grade Protein Production Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Industrial Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Industrial Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Industrial Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Detergent Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Detergent Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Detergent Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Food Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global Food Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global Food Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Pharmaceutical Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Pharmaceutical Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Pharmaceutical Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Research Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Research Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Research Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Academic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Academic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Academic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Industrial Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Industrial Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Industrial Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. Global Autoimmune Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Global Autoimmune Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. Global Autoimmune Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 185. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 188. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 191. Global GMP-grade Protein Production Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Global Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Global Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. Global Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 195. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 198. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 199. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 201. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 202. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 204. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 206. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 207. Global GMP-grade Protein Production Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 208. Asia-Pacific GMP-grade Protein Production Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 209. Asia-Pacific GMP-grade Protein Production Services Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 210. Asia-Pacific GMP-grade Protein Production Services Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 211. Asia-Pacific GMP-grade Protein Production Services Market Size, by Growth Factors, 2017-2032 (USD Million)
TABLE 212. Asia-Pacific GMP-grade Protein Production Services Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 213. Asia-Pacific GMP-grade Protein Production Services Market Size, by Recombinant Proteins, 2017-2032 (USD Million)
TABLE 214. Asia-Pacific GMP-grade Protein Production Services Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 215. Asia-Pacific GMP-grade Protein Production Services Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 216. Asia-Pacific GMP-grade Protein Production Services Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 217. Asia-Pacific GMP-grade Protein Production Services Market Size, by Insect, 2017-2032 (USD Million)
TABLE 218. Asia-Pacific GMP-grade Protein Production Services Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 219. Asia-Pacific GMP-grade Protein Production Services Market Size, by Plant, 2017-2032 (USD Million)
TABLE 220. Asia-Pacific GMP-grade Protein Production Services Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 221. Asia-Pacific GMP-grade Protein Production Services Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 222. Asia-Pacific GMP-grade Protein Production Services Market Size, by Scale, 2017-2032 (USD Million)
TABLE 223. Asia-Pacific GMP-grade Protein Production Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. Asia-Pacific GMP-grade Protein Production Services Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 225. Asia-Pacific GMP-grade Protein Production Services Market Size, by Industrial Enzymes, 2017-2032 (USD Million)
TABLE 226. Asia-Pacific GMP-grade Protein Production Services Market Size, by Research Reagents, 2017-2032 (USD Million)
TABLE 227. Asia-Pacific GMP-grade Protein Production Services Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 228. Asia-Pacific GMP-grade Protein Production Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. North America GMP-grade Protein Production Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 230. North America GMP-grade Protein Production Services Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 231. North America GMP-grade Protein Production Services Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 232. North America GMP-grade Protein Production Services Market Size, by Growth Factors, 2017-2032 (USD Million)
TABLE 233. North America GMP-grade Protein Production Services Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 234. North America GMP-grade Protein Production Services Market Size, by Recombinant Proteins, 2017-2032 (USD Million)
TABLE 235. North America GMP-grade Protein Production Services Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 236. North America GMP-grade Protein Production Services Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 237. North America GMP-grade Protein Production Services Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 238. North America GMP-grade Protein Production Services Market Size, by Insect, 2017-2032 (USD Million)
TABLE 239. North America GMP-grade Protein Production Services Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 240. North America GMP-grade Protein Production Services Market Size, by Plant, 2017-2032 (USD Million)
TABLE 241. North America GMP-grade Protein Production Services Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 242. North America GMP-grade Protein Production Services Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 243. North America GMP-grade Protein Production Services Market Size, by Scale, 2017-2032 (USD Million)
TABLE 244. North America GMP-grade Protein Production Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. North America GMP-grade Protein Production Services Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 246. North America GMP-grade Protein Production Services Market Size, by Industrial Enzymes, 2017-2032 (USD Million)
TABLE 247. North America GMP-grade Protein Production Services Market Size, by Research Reagents, 2017-2032 (USD Million)
TABLE 248. North America GMP-grade Protein Production Services Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 249. North America GMP-grade Protein Production Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Latin America GMP-grade Protein Production Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 251. Latin America GMP-grade Protein Production Services Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 252. Latin America GMP-grade Protein Production Services Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 253. Latin America GMP-grade Protein Production Services Market Size, by Growth Factors, 2017-2032 (USD Million)
TABLE 254. Latin America GMP-grade Protein Production Services Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 255. Latin America GMP-grade Protein Production Services Market Size, by Recombinant Proteins, 2017-2032 (USD Million)
TABLE 256. Latin America GMP-grade Protein Production Services Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 257. Latin America GMP-grade Protein Production Services Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 258. Latin America GMP-grade Protein Production Services Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 259. Latin America GMP-grade Protein Production Services Market Size, by Insect, 2017-2032 (USD Million)
TABLE 260. Latin America GMP-grade Protein Production Services Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 261. Latin America GMP-grade Protein Production Services Market Size, by Plant, 2017-2032 (USD Million)
TABLE 262. Latin America GMP-grade Protein Production Services Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 263. Latin America GMP-grade Protein Production Services Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 264. Latin America GMP-grade Protein Production Services Market Size, by Scale, 2017-2032 (USD Million)
TABLE 265. Latin America GMP-grade Protein Production Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. Latin America GMP-grade Protein Production Services Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 267. Latin America GMP-grade Protein Production Services Market Size, by Industrial Enzymes, 2017-2032 (USD Million)
TABLE 268. Latin America GMP-grade Protein Production Services Market Size, by Research Reagents, 2017-2032 (USD Million)
TABLE 269. Latin America GMP-grade Protein Production Services Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 270. Latin America GMP-grade Protein Production Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. Europe GMP-grade Protein Production Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 272. Europe GMP-grade Protein Production Services Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 273. Europe GMP-grade Protein Production Services Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 274. Europe GMP-grade Protein Production Services Market Size, by Growth Factors, 2017-2032 (USD Million)
TABLE 275. Europe GMP-grade Protein Production Services Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 276. Europe GMP-grade Protein Production Services Market Size, by Recombinant Proteins, 2017-2032 (USD Million)
TABLE 277. Europe GMP-grade Protein Production Services Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 278. Europe GMP-grade Protein Production Services Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 279. Europe GMP-grade Protein Production Services Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 280. Europe GMP-grade Protein Production Services Market Size, by Insect, 2017-2032 (USD Million)
TABLE 281. Europe GMP-grade Protein Production Services Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 282. Europe GMP-grade Protein Production Services Market Size, by Plant, 2017-2032 (USD Million)
TABLE 283. Europe GMP-grade Protein Production Services Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 284. Europe GMP-grade Protein Production Services Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 285. Europe GMP-grade Protein Production Services Market Size, by Scale, 2017-2032 (USD Million)
TABLE 286. Europe GMP-grade Protein Production Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. Europe GMP-grade Protein Production Services Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 288. Europe GMP-grade Protein Production Services Market Size, by Industrial Enzymes, 2017-2032 (USD Million)
TABLE 289. Europe GMP-grade Protein Production Services Market Size, by Research Reagents, 2017-2032 (USD Million)
TABLE 290. Europe GMP-grade Protein Production Services Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 291. Europe GMP-grade Protein Production Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Middle East GMP-grade Protein Production Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 293. Middle East GMP-grade Protein Production Services Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 294. Middle East GMP-grade Protein Production Services Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 295. Middle East GMP-grade Protein Production Services Market Size, by Growth Factors, 2017-2032 (USD Million)
TABLE 296. Middle East GMP-grade Protein Production Services Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 297. Middle East GMP-grade Protein Production Services Market Size, by Recombinant Proteins, 2017-2032 (USD Million)
TABLE 298. Middle East GMP-grade Protein Production Services Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 299. Middle East GMP-grade Protein Production Services Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 300. Middle East GMP-grade Protein Production Services Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 301. Middle East GMP-grade Protein Production Services Market Size, by Insect, 2017-2032 (USD Million)
TABLE 302. Middle East GMP-grade Protein Production Services Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 303. Middle East GMP-grade Protein Production Services Market Size, by Plant, 2017-2032 (USD Million)
TABLE 304. Middle East GMP-grade Protein Production Services Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 305. Middle East GMP-grade Protein Production Services Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 306. Middle East GMP-grade Protein Production Services Market Size, by Scale, 2017-2032 (USD Million)
TABLE 307. Middle East GMP-grade Protein Production Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. Middle East GMP-grade Protein Production Services Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 309. Middle East GMP-grade Protein Production Services Market Size, by Industrial Enzymes, 2017-2032 (USD Million)
TABLE 310. Middle East GMP-grade Protein Production Services Market Size, by Research Reagents, 2017-2032 (USD Million)
TABLE 311. Middle East GMP-grade Protein Production Services Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 312. Middle East GMP-grade Protein Production Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Africa GMP-grade Protein Production Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 314. Africa GMP-grade Protein Production Services Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 315. Africa GMP-grade Protein Production Services Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 316. Africa GMP-grade Protein Production Services Market Size, by Growth Factors, 2017-2032 (USD Million)
TABLE 317. Africa GMP-grade Protein Production Services Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 318. Africa GMP-grade Protein Production Services Market Size, by Recombinant Proteins, 2017-2032 (USD Million)
TABLE 319. Africa GMP-grade Protein Production Services Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 320. Africa GMP-grade Protein Production Services Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 321. Africa GMP-grade Protein Production Services Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 322. Africa GMP-grade Protein Production Services Market Size, by Insect, 2017-2032 (USD Million)
TABLE 323. Africa GMP-grade Protein Production Services Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 324. Africa GMP-grade Protein Production Services Market Size, by Plant, 2017-2032 (USD Million)
TABLE 325. Africa GMP-grade Protein Production Services Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 326. Africa GMP-grade Protein Production Services Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 327. Africa GMP-grade Protein Production Services Market Size, by Scale, 2017-2032 (USD Million)
TABLE 328. Africa GMP-grade Protein Production Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 329. Africa GMP-grade Protein Production Services Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 330. Africa GMP-grade Protein Production Services Market Size, by Industrial Enzymes, 2017-2032 (USD Million)
TABLE 331. Africa GMP-grade Protein Production Services Market Size, by Research Reagents, 2017-2032 (USD Million)
TABLE 332. Africa GMP-grade Protein Production Services Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 333. Africa GMP-grade Protein Production Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 334. Global GMP-grade Protein Production Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 335. ASEAN GMP-grade Protein Production Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 336. ASEAN GMP-grade Protein Production Services Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 337. ASEAN GMP-grade Protein Production Services Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 338. ASEAN GMP-grade Protein Production Services Market Size, by Growth Factors, 2017-2032 (USD Million)
TABLE 339. ASEAN GMP-grade Protein Production Services Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 340. ASEAN GMP-grade Protein Production Services Market Size, by Recombinant Proteins, 2017-2032 (USD Million)
TABLE 341. ASEAN GMP-grade Protein Production Services Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 342. ASEAN GMP-grade Protein Production Services Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 343. ASEAN GMP-grade Protein Production Services Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 344. ASEAN GMP-grade Protein Production Services Market Size, by Insect, 2017-2032 (USD Million)
TABLE 345. ASEAN GMP-grade Protein Production Services Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 346. ASEAN GMP-grade Protein Production Services Market Size, by Plant, 2017-2032 (USD Million)
TABLE 347. ASEAN GMP-grade Protein Production Services Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 348. ASEAN GMP-grade Protein Production Services Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 349. ASEAN GMP-grade Protein Production Services Market Size, by Scale, 2017-2032 (USD Million)
TABLE 350. ASEAN GMP-grade Protein Production Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 351. ASEAN GMP-grade Protein Production Services Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 352. ASEAN GMP-grade Protein Produ

Companies Mentioned

  • AGC Biologics ApS
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Fujifilm Diosynth Biotechnologies, LLC
  • Lonza Group AG
  • Merck KGaA
  • Novasep SA
  • Novozymes
  • Samsung Biologics Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics (Cayman) Inc.

Related Topics

Related Reports

GMP-grade mRNA Production Market - Global Forecast 2026-2032 - Product Image

GMP-grade mRNA Production Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
GMP Protein E Coli Contract Manufacturing Market Outlook 2026-2034: Market Share, and Growth Analysis by Service Type, Product Type, Scale, End User - Product Image

GMP Protein E Coli Contract Manufacturing Market Outlook 2026-2034: Market Share, and Growth Analysis by Service Type, Product Type, Scale, End User

  • Report
  • 160 Pages
  • Global
From
GMP Testing Service Market Size, Share, Trends and Forecast by Service Type, End User, and Region, 2026-2034 - Product Image

GMP Testing Service Market Size, Share, Trends and Forecast by Service Type, End User, and Region, 2026-2034

  • Report
  • 147 Pages
  • Global
From
Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Report 2026 - Product Image

Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Report 2026

  • Report
  • 250 Pages
  • Global
From
GMP Testing Service Market Outlook 2026-2034: Market Share, and Growth Analysis by Service Type, End User - Product Image

GMP Testing Service Market Outlook 2026-2034: Market Share, and Growth Analysis by Service Type, End User

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.